Skip to product information
1 of 1

TCI

CAS 259793-96-9

Favipiravir TCI F1296

Favipiravir TCI F1296

Chemical Identity

Other names
T-705 · T-705 · 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide · 6-Fluoro-3-hydroxypyrazine-2-carboxamide
CAS No.
259793-96-9
PubChem
CID 492405
Formula
C5H4FN3O2
Molecular weight
157.10 g/mol
Purity
>98.0%(HPLC)
Storage
0-10°C
Reference databases
ChEBI·ChemSpider·Wikipedia
Full identifiers (IUPAC, SMILES, InChIKey)
IUPAC
5-fluoro-2-oxo-1H-pyrazine-3-carboxamide
SMILES
C1=C(N=C(C(=O)N1)C(=O)N)F
InChIKey
ZCGNOVWYSGBHAU-UHFFFAOYSA-N
MDL
MDL12032148
Regular price Rp 3.870.300,00
Regular price Sale price Rp 3.870.300,00
Sale Sold out
Shipping calculated at checkout.
Berat
Quantity
Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 2-4 minggu setelah pembayaran.

Dokumen Keamanan & Mutu

CoA (Certificate of Analysis)

Spesifik per batch produksi — diterbitkan dan dikirim bersama barang sesuai nomor lot yang Anda terima.

Contoh CoA segera tersedia.

💬 Minta CoA via WhatsApp

View full details

Favipiravir, with CAS number 259793-96-9, is a chemical compound widely used in scientific research, particularly in the fields of organic chemistry and pharmacology. As a building block, it plays a crucial role in the synthesis of heterocyclic compounds, which are essential in the development of pharmaceuticals and complex chemical materials. Its structural versatility allows researchers to create more intricate molecular structures through various chemical reactions, making it a valuable resource in laboratory settings.

The compound is known for its chemical stability and ability to participate in a range of reactions, including substitution, addition, and coupling reactions. These properties make it a preferred choice for researchers aiming to design molecules with specific functional groups or desired biological activities. Its compatibility with a wide array of reagents further enhances its utility, enabling flexibility in the synthesis of novel compounds.

In Indonesian laboratories, Favipiravir is commonly used in organic and pharmaceutical research. It serves as a key reagent for developing new compounds or studying specific chemical mechanisms. Its availability and reliability make it an essential tool for scientists working on drug discovery and chemical synthesis projects.

Advantages (TCI brochure)

  • Potent and selective viral RNA polymerase inhibitor

  • Organic synthesis applications benefit from Favipiravir’s role as a versatile building block for creating complex heterocyclic structures.
  • Pharmaceutical research utilizes this compound to develop new drugs and understand the mechanisms of chemical reactions involved in drug design.
  • Heterocyclic compound synthesis relies on Favipiravir’s stability and reactivity to form essential molecular frameworks.
  • Chemical reaction mechanism studies use Favipiravir to explore how different reagents interact and influence reaction pathways.
  • Drug development projects incorporate Favipiravir to test and optimize the properties of potential therapeutic agents.

From the TCI brochure

  • Research on antiviral activity against RNA viruses

Brand TCI
CAS number 259793-96-9
Molecular formula —
Purity —
Category Chemistry > Building Blocks > Heterocyclic Building Blocks
Pack sizes Available in various quantities as per standard laboratory supply
Physical form Solid
Storage Store in a cool, dry place away from direct sunlight and moisture

Favipiravir should be stored in a cool, dry environment, away from direct sunlight and moisture to maintain its chemical stability. It is recommended to use airtight containers to prevent exposure to air and humidity, which could affect its integrity. In a laboratory setting, it should be handled with appropriate personal protective equipment, such as gloves and safety goggles, to ensure safety during use. The compound is non-hazardous under normal conditions but should be kept in a secure location to prevent accidental contamination or exposure. Proper labeling of containers is essential to ensure safe handling and storage practices are maintained.

References cited in the TCI brochure

  1. Yousuke Furuta. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections Antiviral Research, 2009. doi:10.1016/j.antiviral.2009.02.198
  2. Sangita Venkataraman. RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution Viruses, 2018. doi:10.3390/v10020076